Hii

Hey there! How can I help you today?

Can you hell me learn pharma

Asking for Preferences

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have excellent content to build a thorough, nurse-friendly pharmacology basics guide. Here it is:

Pharmacology Basics for Nursing Students

Based on Katzung's Basic & Clinical Pharmacology, 16th Edition

1. What Is Pharmacology?

Pharmacology is the study of substances (drugs) that interact with living systems through chemical processes. For nurses, the two most important branches are:

Pharmacokinetics - what the body does to the drug (how it's absorbed, distributed, metabolised, excreted)
Pharmacodynamics - what the drug does to the body (mechanisms of action, effects)

2. What Is a Drug?

A drug is any substance that changes a biological function through chemical action. Most drugs work by binding to a receptor - a specific target molecule that plays a regulatory role in the body.

Agonist - activates the receptor (mimics the body's natural response)
Antagonist - blocks the receptor (prevents the natural response)

Key point: "The dose makes the poison" (Paracelsus, 1493-1541). Any substance can be harmful at the wrong dose - this is why nurses must be precise with drug dosing.

3. Pharmacokinetics: ADME

Think of the acronym ADME - the four processes governing a drug's journey through the body:

A - Absorption

How the drug gets from the administration site into the bloodstream.

Depends on the route of administration (oral, IV, IM, sublingual, transdermal, etc.)
Oral drugs must survive the stomach environment and pass through the gut wall
IV drugs bypass absorption - they go directly into the blood (100% bioavailability)
Lipid-soluble (non-ionized) drugs cross membranes more easily than water-soluble ones

D - Distribution

How the drug spreads from the blood to tissues and organs.

Measured by Volume of Distribution (Vd) - a theoretical volume describing how widely the drug spreads
- High Vd = drug distributes widely into tissues (e.g. fat-soluble drugs)
- Low Vd = drug stays mostly in the blood
Some drugs bind to plasma proteins (mainly albumin); only the free (unbound) fraction is active

M - Metabolism

How the drug is chemically transformed, mainly in the liver.

The liver uses enzymes (especially Cytochrome P450 / CYP enzymes) to break down drugs
Metabolism often converts an active drug to an inactive form for easier elimination
Some drugs are prodrugs - inactive when taken, activated by metabolism (e.g. codeine → morphine)
Drug interactions often happen here - some drugs inhibit or induce CYP enzymes, affecting other drugs' levels

E - Excretion

How the drug is removed from the body.

Primarily via the kidneys (urine) - water-soluble metabolites are excreted
Also via bile, faeces, lungs (inhaled anaesthetics), sweat, breast milk
Patients with kidney or liver disease may need dose adjustments since they can't eliminate drugs normally

4. Key Pharmacokinetic Parameters

Half-Life (t½)

The time required for the amount of drug in the body to decrease by half.

Formula: t½ = 0.7 × Volume of Distribution / Clearance

Why it matters for nurses:

It takes 4-5 half-lives to reach steady-state (when drug levels stabilise)
It also takes 4-5 half-lives to eliminate a drug after stopping it
A drug given every half-life will accumulate; if dosing interval is shorter than 4 half-lives, accumulation is detectable

Drug accumulation and elimination over half-lives

The solid line shows drug accumulating to ~90% steady state after 4 half-lives. The dashed line shows elimination after stopping the drug.

Clearance (CL)

The volume of blood cleared of drug per unit time. Reduced in kidney/liver disease - a critical consideration for safe nursing practice.

5. Pharmacodynamics: How Drugs Work

Drug-Receptor Interaction

Drugs work by binding to receptors and either:

Activating them (agonist) - produces a response
Blocking them (antagonist) - prevents a response

Dose-Response Relationship

ED50 - the dose that produces 50% of the maximum effect
Therapeutic window - the range between the effective dose and the toxic dose
Therapeutic index - ratio of toxic dose to effective dose; a narrow therapeutic index (e.g. digoxin, warfarin, lithium) means careful monitoring is needed

6. Routes of Administration - A Nursing Quick-Reference

Route	Onset	Key Notes
IV (intravenous)	Fastest (seconds-minutes)	100% bioavailable; no absorption step
IM (intramuscular)	Minutes	Good for some vaccines and emergencies
SC (subcutaneous)	Slower than IM	Used for insulin, heparin
Oral (PO)	Slowest (30-60 min)	Most convenient; first-pass metabolism
Sublingual	Fast (minutes)	Bypasses first-pass (e.g. nitroglycerin)
Transdermal	Very slow (hours)	Sustained release (e.g. nicotine patch)

7. First-Pass Effect (Hepatic First-Pass Metabolism)

When a drug is taken orally, it is absorbed from the gut and travels first to the liver via the portal vein before reaching systemic circulation. The liver may metabolise a large fraction of the drug before it even reaches its target.

Drugs with high first-pass effect (e.g. morphine, nitroglycerin) have low oral bioavailability
This is why nitroglycerin is given sublingually (under the tongue) - it bypasses the liver

8. Drug Interactions - Basics

Pharmacokinetic interactions - one drug alters the absorption, distribution, metabolism, or excretion of another
- Example: rifampicin induces CYP enzymes → lowers levels of other drugs metabolised by the same enzymes
- Example: fluconazole inhibits CYP enzymes → raises levels of other drugs (risk of toxicity)
Pharmacodynamic interactions - two drugs have additive, synergistic, or antagonistic effects at their receptors
- Example: two CNS depressants (opioids + benzodiazepines) together cause additive respiratory depression

9. Special Populations (Important for Nursing!)

Population	Key Concern
Elderly patients	Reduced renal/hepatic function; increased drug sensitivity; start low, go slow
Renal failure	Reduced excretion; drugs accumulate; dose adjustment needed
Hepatic failure	Reduced metabolism; active drug builds up
Pregnant patients	Drug may cross placenta; fetal harm risk; check pregnancy category
Paediatric patients	Different weight-based dosing; immature enzyme systems

Where to Go Next

Once you're comfortable with these basics, good next topics to study are:

Autonomic pharmacology (sympathomimetics, beta-blockers, anticholinergics)
Analgesics (opioids, NSAIDs)
Antibiotics (mechanisms and resistance)
Cardiovascular drugs (antihypertensives, antiarrhythmics, diuretics)
Drug calculations (doses, drip rates, unit conversions)

Would you like me to go deeper into any of these sections, or move on to a specific drug class you'll be encountering in clinical practice?

Explain drug calculations and dosing for clinical practice

Reading File

Finding Sources

Reading File

Excellent content from both Katzung and Lippincott. Now I have everything needed for a thorough, practical guide.

Drug Calculations & Dosing for Clinical Practice

Based on Katzung's Basic & Clinical Pharmacology 16e and Lippincott Illustrated Reviews: Pharmacology

Part 1 - The Master Formula (The Foundation of All Drug Calculations)

The single most important formula in nursing practice:

$$\text{Volume to give} = \frac{\text{Desired Dose}}{\text{Available Dose}} \times \text{Available Volume}$$

Example:

Doctor orders: 250 mg of amoxicillin
On hand: amoxicillin 500 mg / 5 mL suspension

$$\text{Volume} = \frac{250\text{ mg}}{500\text{ mg}} \times 5\text{ mL} = \mathbf{2.5 mL}$$

Part 2 - Weight-Based Dosing (mg/kg)

Used for most paediatric drugs, heparin, antibiotics, chemotherapy, and many critical care drugs.

$$\text{Total Dose} = \text{Weight (kg)} \times \text{Dose (mg/kg)}$$

Example:

Child weighs 20 kg, doctor orders amoxicillin 25 mg/kg/day in 2 divided doses
Total daily dose = 20 × 25 = 500 mg/day
Each dose = 500 ÷ 2 = 250 mg twice daily

Then apply the master formula to calculate the volume to draw up.

Part 3 - IV Infusion Rate Calculations

3a. mL per Hour

Used when a pump is available (most modern wards):

$$\text{Rate (mL/hr)} = \frac{\text{Volume to infuse (mL)}}{\text{Time (hours)}}$$

Example: Infuse 1000 mL of normal saline over 8 hours $$\text{Rate} = \frac{1000}{8} = \mathbf{125 \text{ mL/hr}}$$

3b. Drops per Minute (Manual Drip - no pump)

Used in settings without infusion pumps. You need to know the drop factor of the IV giving set:

Standard giving set: 20 drops/mL
Blood/high-viscosity giving set: 15 drops/mL
Micro-drip/paediatric giving set: 60 drops/mL

$$\text{Drops/min} = \frac{\text{Volume (mL)} \times \text{Drop factor}}{\text{Time (minutes)}}$$

Example: 500 mL over 4 hours using a standard set (20 drops/mL) $$\text{Drops/min} = \frac{500 \times 20}{4 \times 60} = \frac{10000}{240} \approx \mathbf{42 \text{ drops/min}}$$

3c. Drug Infusion Rate (mcg/kg/min)

Common in ICU - for vasopressors (dopamine, noradrenaline), heparin, insulin infusions:

$$\text{Infusion rate (mL/hr)} = \frac{\text{Dose (mcg/kg/min)} \times \text{Weight (kg)} \times 60}{\text{Concentration (mcg/mL)}}$$

Example: Dopamine ordered at 5 mcg/kg/min for a 70 kg patient. Bag = dopamine 400 mg in 250 mL (concentration = 400,000 mcg ÷ 250 mL = 1600 mcg/mL)

$$\text{Rate} = \frac{5 \times 70 \times 60}{1600} = \frac{21000}{1600} \approx \mathbf{13.1 \text{ mL/hr}}$$

Part 4 - Loading Dose vs Maintenance Dose

This is a key clinical concept. According to Katzung:

"In most clinical situations, drugs are administered so as to maintain a steady state of drug in the body, where the amount given with each dose replaces the drug eliminated since the preceding dose."

Maintenance Dose

Keeps the drug at a stable therapeutic level (steady-state concentration, or Css).

It takes 4-5 half-lives to reach steady state from zero
Formula: Dosing Rate = Clearance (CL) × Target Concentration (TC)

Loading Dose

Given when you need to reach therapeutic levels quickly - particularly for drugs with long half-lives (e.g. digoxin, amiodarone, phenytoin).

$$\text{Loading Dose} = V_d \times \text{Target Concentration (TC)}$$

Example from Katzung (theophylline):

Target plasma level = 10 mg/L
Volume of distribution (Vd) = 35 L (for a 70 kg person)
Loading dose = 35 × 10 = 350 mg (given as a single dose to rapidly reach target)
Maintenance dose = 350 mg every 12 hrs orally to keep that level

With a loading dose (red line), therapeutic levels are reached immediately. Without it (blue line), it takes 4-5 half-lives to reach steady state.

Nursing caution: Loading doses carry increased toxicity risk. IV loading doses must be given slowly (e.g. over an hour, NOT by rapid bolus) to prevent dangerously high initial concentrations - especially for phenytoin, digoxin, and amiodarone.

Part 5 - Therapeutic Drug Monitoring (TDM)

Some drugs have a narrow therapeutic index - the gap between the effective dose and the toxic dose is small. These drugs must be monitored with blood levels.

Drug	Therapeutic Range	Toxic Signs to Watch For
Digoxin	0.5-2 ng/mL	Nausea, bradycardia, visual changes
Lithium	0.6-1.2 mEq/L	Tremor, confusion, arrhythmia
Warfarin	INR 2-3 (most indications)	Bleeding
Phenytoin	10-20 mcg/mL	Nystagmus, ataxia, confusion
Gentamicin	Peak 5-10 mcg/mL	Nephrotoxicity, ototoxicity
Theophylline	10-20 mcg/mL	Nausea, seizures, arrhythmia

From Lippincott Illustrated Reviews: Pharmacology - "If the therapeutic window of the drug is small (for example, digoxin or lithium), extra caution should be taken in selecting a dosage regimen, and drug levels should be monitored."

Part 6 - Dose Adjustments in Special Populations

Renal Impairment

Kidneys are the primary route of excretion for most drugs
Reduced clearance → drug accumulates → toxicity risk
Key dose reduction formula using creatinine clearance (CrCl) - calculated by the Cockcroft-Gault equation:

$$\text{CrCl (mL/min)} = \frac{(140 - \text{age}) \times \text{weight (kg)}}{72 \times \text{serum creatinine (mg/dL)}} \times (0.85 \text{ if female})$$

If CrCl is reduced, the dose is reduced or the interval is extended
Drugs needing renal dose adjustment include: gentamicin, metformin, digoxin, many antibiotics

Hepatic Impairment

Liver metabolises most drugs via CYP enzymes
Reduced metabolism → higher drug levels → toxicity
Particularly relevant for: morphine, warfarin, statins, antifungals

Elderly Patients

Reduced renal AND hepatic function
Lower body weight and higher fat/muscle ratio changes Vd
Principle: "Start low, go slow"

Paediatric Patients

Immature liver enzymes (especially in neonates)
Always dose by weight (mg/kg) - never extrapolate adult doses
Dose adjustment reference: Harriet Lane Handbook

Part 7 - The 5 Rights of Medication Administration (Never Skip These)

Before giving any drug, verify:

Right	What to Check
Right Patient	Two identifiers (name + DOB or ID)
Right Drug	Correct medication name (generic vs brand confusion is common)
Right Dose	Recalculate - never assume someone else's calculation
Right Route	Oral, IV, IM, sublingual, topical, etc.
Right Time	Correct frequency and timing relative to meals/other drugs

Some institutions add: Right Documentation, Right Reason, Right Response.

Part 8 - Quick Reference: Unit Conversions for Drug Calculations

From	To	Multiply by
grams (g)	milligrams (mg)	× 1,000
milligrams (mg)	micrograms (mcg / μg)	× 1,000
micrograms (mcg)	nanograms (ng)	× 1,000
kilograms (kg)	pounds (lb)	× 2.2
litres (L)	millilitres (mL)	× 1,000

Common trap: Orders may be written in mcg but your drug vial may be labelled in mg. Always convert to the same unit before calculating.

Practice Questions

Try these to test yourself:

Q1. A doctor orders gentamicin 80 mg IV. On hand: gentamicin 40 mg/mL. How many mL do you draw up?

Q2. Infuse 500 mL of D5W over 6 hours. What is the rate in mL/hr?

Q3. A child weighs 15 kg. The order is paracetamol 15 mg/kg. The suspension is 250 mg/5 mL. What volume do you give?

Q4. Heparin infusion running at 25,000 units in 500 mL. Patient needs 1,000 units/hr. What is the pump rate in mL/hr?

(Answers: Q1 = 2 mL, Q2 = 83.3 mL/hr, Q3 = 4.5 mL, Q4 = 20 mL/hr)

Would you like me to go deeper on any of these areas - for example, heparin/insulin infusion calculations, paediatric dosing, or practice a set of worked examples together?

Which drug should be given together

Asking for Preferences

Not be given together

Finding Sources

Reading File

Finding Sources

Excellent - I now have rich, textbook-backed content across all the major dangerous drug combinations. Here's a comprehensive guide:

Dangerous Drug Combinations - What Must NOT Be Given Together

Based on Tintinalli's Emergency Medicine, Katzung's Basic & Clinical Pharmacology 16e, Goodman & Gilman's, and The Washington Manual

The Big Categories of Dangerous Drug Interactions

There are two main types of interactions that cause harm:

Pharmacokinetic - one drug changes how the body processes another (absorption, metabolism, excretion) - leading to toxic levels or sub-therapeutic levels
Pharmacodynamic - two drugs have additive or opposing effects at the same receptors - leading to exaggerated or dangerous responses

1. MAOIs + Serotonergic Drugs → Serotonin Syndrome (Life-Threatening)

This is one of the most dangerous combinations in all of pharmacology.

MAOIs (Monoamine Oxidase Inhibitors):

Phenelzine, tranylcypromine, isocarboxazid (antidepressants)
Selegiline (Parkinson's)
Linezolid (antibiotic - often forgotten!)
Methylene blue (used in surgeries - often forgotten!)

NEVER combine MAOIs with:

Drug	Why Dangerous
SSRIs (fluoxetine, sertraline, etc.)	Massive serotonin excess
SNRIs (venlafaxine, duloxetine)	Massive serotonin excess
Meperidine (pethidine)	Fatal serotonin syndrome
Tramadol	Serotonin + seizure risk
Dextromethorphan (cough syrups)	Serotonin syndrome
Cocaine, MDMA, methamphetamine	Severe serotonergic + adrenergic crisis

What happens: Fever, agitation, muscle rigidity, tremor, diarrhoea, fast heart rate, seizures, and death.

Washout rule (from Tintinalli's): SSRIs/SNRIs must be stopped 2 weeks before starting an MAOI. Fluoxetine needs 4 weeks (long half-life). After stopping an MAOI, wait 2 weeks before starting any serotonergic drug - because it takes 2 weeks for MAO enzyme activity to recover 50%.

2. Opioids + Benzodiazepines → Fatal Respiratory Depression

This is the most common drug combination contributing to overdose deaths.

Examples:

Morphine/oxycodone/codeine/fentanyl + diazepam/midazolam/lorazepam/alprazolam

Why so dangerous: Both drug classes independently depress the central nervous system and slow breathing. Together, the effect is additive to synergistic - patients stop breathing.

From Rosen's Emergency Medicine: "Among opioid overdose deaths, one-third have benzodiazepine present."

Nursing alert: If a patient on both drugs becomes drowsy or their respiratory rate drops below 12/min, act immediately. Have naloxone (Narcan) ready.

Also avoid combining opioids with:

Alcohol
Antihistamines (promethazine, diphenhydramine)
Muscle relaxants (cyclobenzaprine)
Antipsychotics
Any other CNS depressant

3. Warfarin + NSAIDs → Severe Bleeding

Why it's dangerous	Mechanism
NSAIDs inhibit platelet function	Pharmacodynamic - impairs clotting
NSAIDs displace warfarin from plasma proteins	Pharmacokinetic - raises free warfarin levels
NSAIDs cause gastric ulcers	Increases GI bleeding risk directly

From Rosen's: "NSAIDs displace protein-bound warfarin and cause subsequent increases in prothrombin times at a constant warfarin dose. NSAID use is generally avoided in patients who are taking warfarin."

Practical rule: Patients on warfarin should use paracetamol (acetaminophen) for pain relief instead of ibuprofen/naproxen/aspirin (except low-dose aspirin when specifically prescribed for cardiac protection - which itself requires careful monitoring).

4. ACE Inhibitors/ARBs + Potassium-Sparing Diuretics → Life-Threatening Hyperkalemia

The dangerous combination:

ACE inhibitors (lisinopril, enalapril, ramipril) OR ARBs (losartan, valsartan)
PLUS potassium-sparing diuretics (spironolactone, amiloride) or potassium supplements

Why: ACE inhibitors reduce aldosterone → retain potassium. Potassium-sparing diuretics also retain potassium. Together, potassium can rise to dangerous levels causing life-threatening cardiac arrhythmias.

Also avoid ACE inhibitor/ARB + ACE inhibitor/ARB (double blockade - causes severe hypotension and acute kidney injury)

From The Washington Manual: "Oral potassium supplements, potassium salt substitutes, and potassium-sparing diuretics should be used with caution during treatment with an ACE inhibitor."

5. QT-Prolonging Drugs Taken Together → Torsades de Pointes (Fatal Arrhythmia)

Many drugs independently prolong the QT interval on an ECG. Combining them multiplies the risk of a fatal ventricular arrhythmia called Torsades de Pointes.

Common QT-prolonging drugs to NOT combine:

Drug Class	Examples
Antiarrhythmics	Amiodarone, sotalol, quinidine
Antipsychotics	Haloperidol, quetiapine, ziprasidone
Antibiotics	Azithromycin, ciprofloxacin, clarithromycin
Antifungals	Fluconazole, ketoconazole
Antiemetics	Ondansetron (especially IV, high dose), domperidone
Antidepressants	Citalopram (high doses), tricyclics

High-risk combinations to flag: Azithromycin + ondansetron, amiodarone + fluconazole, haloperidol + ciprofloxacin.

Nursing action: Check a baseline ECG before starting these drugs. Report QTc > 500 ms to the prescriber.

6. Azathioprine + Allopurinol → Severe Bone Marrow Toxicity

From Fitzpatrick's Dermatology: "A major drug interaction occurs between azathioprine and allopurinol. When allopurinol must be used concurrently with azathioprine, the azathioprine dose should be decreased by 75%."

Why: Allopurinol inhibits xanthine oxidase, the enzyme that breaks down azathioprine. Azathioprine accumulates to toxic levels, suppressing the bone marrow → dangerous fall in white cells, red cells, and platelets.

7. Methotrexate + NSAIDs → Methotrexate Toxicity

NSAIDs reduce kidney blood flow and compete with methotrexate for renal tubular secretion. Methotrexate builds up → bone marrow suppression, mucositis, liver and kidney damage.

Rule: NSAIDs are generally avoided in patients on methotrexate, especially high-dose regimens.

8. Other Important Combinations to Avoid

Combination	Risk
Statins + strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole)	Statin toxicity → rhabdomyolysis (muscle breakdown)
Digoxin + amiodarone or verapamil	Digoxin toxicity (raised blood levels)
Lithium + NSAIDs or thiazide diuretics	Lithium toxicity (reduced renal excretion)
Metformin + IV contrast dye	Lactic acidosis (metformin must be held 48 hrs before/after contrast)
Valproic acid + lamotrigine	Doubles lamotrigine levels → toxicity
Alcohol + metronidazole or tinidazole	Disulfiram-like reaction (flushing, vomiting, tachycardia)
Sildenafil (Viagra) + nitrates	Severe, potentially fatal hypotension
Linezolid + SSRIs/SNRIs	Serotonin syndrome (linezolid is a weak MAOI!)

Quick Summary Table - Critical Interactions

Drug A	Drug B	Danger
MAOIs	SSRIs / meperidine / tramadol	Serotonin syndrome - FATAL
Opioids	Benzodiazepines	Respiratory arrest - FATAL
Warfarin	NSAIDs	Severe bleeding
ACE inhibitor	Potassium-sparing diuretics	Dangerous hyperkalemia
QT drugs	Other QT drugs	Torsades - fatal arrhythmia
Azathioprine	Allopurinol	Bone marrow failure
Sildenafil	Nitrates	Severe hypotension
Alcohol	Metronidazole	Disulfiram reaction
Methotrexate	NSAIDs	Methotrexate toxicity
Digoxin	Amiodarone / verapamil	Digoxin toxicity

Nursing Safety Checklist Before Giving Any Drug

Check the full medication list - look at ALL drugs the patient is on
Flag high-risk drugs - warfarin, digoxin, lithium, methotrexate, MAOIs, opioids, QT-prolonging drugs
Ask about OTC drugs and herbal supplements - patients often don't volunteer this (St John's Wort is a major CYP inducer that interacts with many drugs)
Check renal and liver function - many interactions are worse in organ impairment
Use a drug interaction checker - apps like Lexicomp, Epocrates, or Micromedex are standard in clinical practice

Would you like me to go deeper into any specific combination - such as IV drug compatibilities (what can share the same IV line), or move on to another pharmacology topic like antibiotics or cardiac drugs?

This is a shared conversation. Sign in to Orris to start your own chat.